Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning - a Multicenter Interrupted Time Series Study (INVERT Study)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6,525
- 试验地点
- 1
- 主要终点
- Application of Objective Neuromuscular Monitoring (Acceleromyography) in Cases Receiving a Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine) (Yes/no)
研究概览
简要总结
To assess the impact of an e-learning course in neuromuscular monitoring on the frequency of application of objective neuromuscular monitoring for assessment of depth of neuromuscular blockade in general anaesthesia and secondarily on the incidence of residual neuromuscular blockade after anesthesia.
We will collect data prospectively from 6 Danish anaesthesia departments from the time of intervention, using data from the Anaesthesia Information Management System (AIMS). Baseline data is obtained from another study based on the same data extraction procedure (NCT02914119).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inclusion Departments We will include the 6 largest anaesthesia departments in the Zealand Region of Denmark.
- •Anaesthetists We will include the following anaesthesia personnel as anaesthetists: nurse anaesthetists in training, nurse anaesthetists, first year residents in anaesthesiology, residents in the last 4 years of training in anaesthesiology, and specialist consultants in anaesthesia.
- •Patients We will include and collect data from all patients undergoing general anaesthesia with neuromuscular blockade in each data collection period. Patients, who are eligible more than once, i.e. undergoing general anaesthesia on more than one occasion, will be included in the analyses with a case for every general anaesthetic received.
排除标准
- •We will exclude personnel without clinical functions, i.e. administrative personnel.
研究组 & 干预措施
E-learning course
干预措施: E-learning course in neuromuscular monitoring (Other)
结局指标
主要结局
Application of Objective Neuromuscular Monitoring (Acceleromyography) in Cases Receiving a Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine) (Yes/no)
时间窗: in the period from induction of anaesthesia to termination of anaesthesia, usually 2 hours
Number of Participants Who Received a Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine) and was Monitored with Objective Neuromuscular Monitoring (Acceleromyography). Data on neuromuscular monitoring is automatically registered in the electronic patient chart when the equipment for acceleromyography is activated.
Application of Objective Neuromuscular Monitoring (Acceleromyography) in Cases Receiving a Non-depolarizing NMBA (Yes/no)
时间窗: in the period from induction of anaesthesia to termination of anaesthesia, usually 2 hours
Number of Participants Who Received a Non-depolarizing Neuromuscular Blocking Agent (NMBA) and was Monitored with Objective Neuromuscular Monitoring (Acceleromyography). Data on neuromuscular monitoring is automatically registered in the electronic patient chart when the equipment for acceleromyography is activated.
次要结局
- Time in Minutes From Tracheal Extubation or Removal of Supraglottic Airway Device to Discharge From Post-anaesthesia Care Unit in Cases Involving a Non-depolarizing NMBA(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 180 minutes)
- Administration of Neostigmine in Cases Receiving a Non-depolarizing NMBA (Yes/no)(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 5 hours)
- Administration of More Than One Reversal Agent in Cases Receiving a Non-depolarizing NMBA (Yes/no)(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 5 hours)
- Last Recorded Train-of-four (TOF) Ratio Before Tracheal Extubation or Removal of Supraglottic Airway Device in Patients Receiving a Non-depolarizing NMBA(in the period from induction of anaesthesia to termination of anaesthesia, usually 2 hours])
- Administration of Sugammadex in Cases Receiving a Non-depolarizing NMBA (Yes/no)(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 5 hours)